Targeting DNA to Cells with Basic Fibroblast Growth Factor (FGF2)

This publication has 29 references indexed in Scilit:

• Local Infusion of FGF-Saporin Reduces Intimal Hyperplasia
  Journal of Surgical Research, 1996
• Heparan sulfate fibroblast growth factor receptor complex: Structure‐function relationships
  Molecular Reproduction and Development, 1994
• Anti-B16-F10 melanoma activity of a basic fibroblast growth factor-saporin mitotoxin
  Cancer, 1994
• Fibroblast growth factor-2 (FGF-2) in the nucleus: Translocation process and targets
  Biochemical Pharmacology, 1994
• Reducing the Heterogeneity of Chemically Conjugated Targeted Toxins: Homogeneous Basic FGF-Saporin
  Analytical Biochemistry, 1993
• Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors.
  Proceedings of the National Academy of Sciences, 1992
• Requirement of Heparan Sulfate for bFGF-Mediated Fibroblast Growth and Myoblast Differentiation
  Science, 1991
• Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
  Cell, 1991
• Interaction of heparin with human basic fibroblast growth factor: Protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan
  Journal of Cellular Physiology, 1989
• Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation.
  The Journal of cell biology, 1988